Literature DB >> 27149967

Diabetes and Cardiovascular Care Among People with Severe Mental Illness: A Literature Review.

Christina Mangurian1,2,3, John W Newcomer4, Chelsea Modlin5, Dean Schillinger6,7,8.   

Abstract

Close to 19 million US adults have severe mental illnesses (SMI), and they die, on average, 25 years earlier than the general population, most often from cardiovascular disease (CVD). Many of the antipsychotic medications used to treat SMI contribute to CVD risk by increasing risk for obesity, type 2 diabetes, dyslipidemia, and hypertension. Based on compelling evidence, the American Diabetes Association and the American Psychiatric Association developed guidelines for metabolic screening and monitoring during use of these medications.In this manuscript, we have reviewed the evidence on diabetes and other CVD risk screening, prevalence, and management among populations with SMI. We also review differences in screening among subpopulations with SMI (e.g., racial/ethnic minorities, women, and children). We found that despite national guidelines for screening for diabetes and other cardiovascular risk factors, up to 70 % of people taking antipsychotics remain unscreened and untreated. Based on estimates that 20 % of the 19 million US adults with SMI have diabetes and 70 % of them are not screened; it is likely that over 2 million Americans with SMI have unidentified diabetes. Given that undiagnosed diabetes costs over $4,000 per person, this failure to identify diabetes among people with SMI represents a missed opportunity to prevent morbidity and translates to over $8 billion in annual preventable costs to our healthcare system.Given the high burden of disease and significant evidence of suboptimal medical care received by people with SMI, we propose several clinical and policy recommendations to improve diabetes and other CVD risk screening and care for this highly vulnerable population. These recommendations include reducing antipsychotic medication dose or switching antipsychotic medications, enhancing smoking cessation efforts, sharing electronic health records between physical and mental health care systems, and promoting integration of care.

Entities:  

Keywords:  diabetes; integration of care; mental illness

Mesh:

Year:  2016        PMID: 27149967      PMCID: PMC4978675          DOI: 10.1007/s11606-016-3712-4

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  103 in total

Review 1.  Switching antipsychotic therapies.

Authors:  P S Masand; S L Berry
Journal:  Ann Pharmacother       Date:  2000-02       Impact factor: 3.154

2.  Efficacy of initiating tobacco dependence treatment in inpatient psychiatry: a randomized controlled trial.

Authors:  Judith J Prochaska; Stephen E Hall; Kevin Delucchi; Sharon M Hall
Journal:  Am J Public Health       Date:  2013-08-15       Impact factor: 9.308

3.  The 2014 Surgeon General's report: commemorating the 50th Anniversary of the 1964 Report of the Advisory Committee to the US Surgeon General and updating the evidence on the health consequences of cigarette smoking.

Authors:  Anthony J Alberg; Donald R Shopland; K Michael Cummings
Journal:  Am J Epidemiol       Date:  2014-01-15       Impact factor: 4.897

4.  Randomized Controlled Trial of a Healthy Lifestyle Intervention Among Smokers With Psychotic Disorders.

Authors:  Amanda L Baker; Robyn Richmond; Frances J Kay-Lambkin; Sacha L Filia; David Castle; Jill M Williams; Terry J Lewin; Vanessa Clark; Robin Callister; Natasha Weaver
Journal:  Nicotine Tob Res       Date:  2015-03-05       Impact factor: 4.244

5.  Roles in and barriers to metabolic screening for people taking antipsychotic medications: a survey of psychiatrists.

Authors:  S G Parameswaran; C Chang; A K Swenson; M Shumway; M Olfson; C V Mangurian
Journal:  Schizophr Res       Date:  2012-12-09       Impact factor: 4.939

6.  A review of pharmacologic strategies for switching to atypical antipsychotics.

Authors:  Prakash S Masand
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

7.  A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder.

Authors:  Amanda Baker; Robyn Richmond; Melanie Haile; Terry J Lewin; Vaughan J Carr; Rachel L Taylor; Sylvia Jansons; Kay Wilhelm
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

8.  A randomized trial of medical care management for community mental health settings: the Primary Care Access, Referral, and Evaluation (PCARE) study.

Authors:  Benjamin G Druss; Silke A von Esenwein; Michael T Compton; Kimberly J Rask; Liping Zhao; Ruth M Parker
Journal:  Am J Psychiatry       Date:  2009-12-15       Impact factor: 18.112

9.  Patterns of primary care and mortality among patients with schizophrenia or diabetes: a cluster analysis approach to the retrospective study of healthcare utilization.

Authors:  Laurel A Copeland; John E Zeber; Chen-Pin Wang; Michael L Parchman; Valerie A Lawrence; Marcia Valenstein; Alexander L Miller
Journal:  BMC Health Serv Res       Date:  2009-07-26       Impact factor: 2.655

Review 10.  Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis.

Authors:  David P J Osborn; Christine A Wright; Gus Levy; Michael B King; Raman Deo; Irwin Nazareth
Journal:  BMC Psychiatry       Date:  2008-09-25       Impact factor: 3.630

View more
  26 in total

1.  Integrating physical health: What were the costs to behavioral health care clinics?

Authors:  Kathryn L Connor; Joshua Breslau; Molly T Finnerty; Emily Leckman-Westin; Riti Pritam; Hao Yu
Journal:  Gen Hosp Psychiatry       Date:  2017-12-20       Impact factor: 3.238

Review 2.  Physical Health and Drug Safety in Individuals with Schizophrenia.

Authors:  Tamara Pringsheim; Martina Kelly; Doug Urness; Michael Teehan; Zahinoor Ismail; David Gardner
Journal:  Can J Psychiatry       Date:  2017-07-18       Impact factor: 4.356

3.  Comorbid Diabetes and Severe Mental Illness: Outcomes in an Integrated Health Care Delivery System.

Authors:  Christina Mangurian; Dean Schillinger; John W Newcomer; Eric Vittinghoff; Susan Essock; Zheng Zhu; Wendy Dyer; Kelly C Young-Wolff; Julie Schmittdiel
Journal:  J Gen Intern Med       Date:  2019-11-08       Impact factor: 5.128

Review 4.  Mental and Addictive Disorders and Medical Comorbidities.

Authors:  Elizabeth Reisinger Walker; Benjamin G Druss
Journal:  Curr Psychiatry Rep       Date:  2018-08-28       Impact factor: 5.285

5.  Breast Cancer Screening in Women With Schizophrenia: A Systematic Review and Meta-Analysis.

Authors:  Alison Hwong; Kara Wang; Stephen Bent; Christina Mangurian
Journal:  Psychiatr Serv       Date:  2019-11-14       Impact factor: 3.084

6.  Impact of a Mental Health Based Primary Care Program on Quality of Physical Health Care.

Authors:  Joshua Breslau; Emily Leckman-Westin; Hao Yu; Bing Han; Riti Pritam; Diana Guarasi; Marcela Horvitz-Lennon; Deborah M Scharf; Harold A Pincus; Molly T Finnerty
Journal:  Adm Policy Ment Health       Date:  2018-03

7.  Race analysis in an African American sample with serious mental illness and comorbid diabetes.

Authors:  Martha Sajatovic; Molly Howland; Douglas Gunzler; Stephanie W Kanuch; Kristin A Cassidy; Richard McCormick; Mark S Bauer; Thomas Scheidemantel; Charles Thomas; Carol Blixen; Neal V Dawson
Journal:  Psychiatr Rehabil J       Date:  2018-09

8.  Medical comorbid diagnoses among adult psychiatric inpatients.

Authors:  Matthew L Goldman; Christina Mangurian; Tom Corbeil; Melanie M Wall; Fei Tang; Morgan Haselden; Susan M Essock; Eric Frimpong; Franco Mascayano; Marleen Radigan; Matthew Schneider; Rui Wang; Lisa B Dixon; Mark Olfson; Thomas E Smith
Journal:  Gen Hosp Psychiatry       Date:  2020-06-23       Impact factor: 3.238

9.  Computerized Conjoint Analysis of the Weight Treatment Preferences of Individuals With Schizophrenia.

Authors:  Nichole Goodsmith; Amy N Cohen; Anthony W P Flynn; Alison B Hamilton; Gerhard Hellemann; Nancy Nowlin-Finch; Alexander S Young
Journal:  Psychiatr Serv       Date:  2021-01-12       Impact factor: 3.084

10.  Smoking cessation treatment for individuals with comorbid diabetes and serious mental illness in an integrated health care delivery system.

Authors:  Alison R Hwong; Julie Schmittdiel; Dean Schillinger; John W Newcomer; Susan Essock; Zheng Zhu; Wendy Dyer; Kelly C Young-Wolff; Christina Mangurian
Journal:  Addict Behav       Date:  2020-10-14       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.